Generated by Yoast SEO v25.8, this is an llms.txt file, meant for consumption by LLMs.

The XML sitemap of this website can by found by following [this link](https://crinetics.com/sitemap_index.xml).

# Crinetics: Driving the Next Generation of Endocrinology Care

## Pages
- [Our Company](https://crinetics.com/our-company/)
- [Contact Us](https://crinetics.com/contact/)
- [Terms of Use](https://crinetics.com/terms/)
- [Privacy Policy](https://crinetics.com/privacy-policy/)
- [Therapeutic Areas](https://crinetics.com/clinical-development-therapeutic-areas/)
- [Our Science](https://crinetics.com/focus-areas/)
- [Pipeline](https://crinetics.com/pipeline/)
- [Publications](https://crinetics.com/publications/)
- [Featured Perspectives](https://crinetics.com/featured-perspectives/)
- [Careers](https://crinetics.com/careers/)
- [News \& Events](https://crinetics.com/news-events/)

## Posts
- [Crinetics Pharmaceuticals Announces November 2025 Inducement Grants Under Nasdaq Listing Rule 5635\(c\)\(4\)](https://crinetics.com/crinetics-pharmaceuticals-announces-november-2025-inducement-grants-under-nasdaq-listing-rule-5635c4/): Crinetics grants non\-qualified stock option awards to purchase an aggregate of 37,675   shares of its common stock and granted an aggregate of 25,300 restricted stock unit \(“RSU”\) awards to 11 new non\-executive employees
- [Webcast: Crinetics Pharmaceuticals to Report Third Quarter 2025 Financial Results](https://crinetics.com/webcast-crinetics-pharmaceuticals-to-report-third-quarter-2025-financial-results/): Crinetics company management will report third quarter 2025 financial results on Thursday, November 6, 2025 after the market closes\. 
- [Crinetics Pharmaceuticals Reports Third Quarter 2025 Financial Results  and Provides Business Update](https://crinetics.com/crinetics-pharmaceuticals-reports-third-quarter-2025-financial-results-and-provides-business-update/): Crinetics Pharmaceuticals reports third quarter 2025 financial results and provided a business update on November 6, 2025 at 4:30PM ET\. 
- [NANETS 2025: Reimagining Treatment for Carcinoid Syndrome](https://crinetics.com/nanets-2025-reimagining-treatment-for-carcinoid-syndrome/)
- [Crinetics to Highlight Neuroendocrine Tumor Research Progress at the 2025 North American Neuroendocrine Tumor Society Annual Meeting](https://crinetics.com/crinetics-to-highlight-neuroendocrine-tumor-research-progress-at-the-2025-north-american-neuroendocrine-tumor-society-annual-meeting/)